GPT Healthcare [GPTHEALTH] vs Dr. Agarwal's Eye [DRAGARWQ] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: GPT Healthcare Ltd. wins in 9 metrics, Dr. Agarwal's Eye Hospital Ltd. wins in 11 metrics, with 0 ties. Dr. Agarwal's Eye Hospital Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | GPT Healthcare Ltd. | Dr. Agarwal's Eye Hospital Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 27.54 | 34.01 | GPT Healthcare Ltd. |
| Price-to-Book Ratio | 4.41 | 7.52 | GPT Healthcare Ltd. |
| Debt-to-Equity Ratio | 38.28 | 106.45 | GPT Healthcare Ltd. |
| PEG Ratio | -1.17 | 1.81 | Dr. Agarwal's Eye Hospital Ltd. |
| EV/EBITDA | 17.00 | 20.64 | GPT Healthcare Ltd. |
| Profit Margin (TTM) | 9.06% | 15.50% | Dr. Agarwal's Eye Hospital Ltd. |
| Operating Margin (TTM) | 11.32% | 19.54% | Dr. Agarwal's Eye Hospital Ltd. |
| EBITDA Margin (TTM) | 11.32% | 19.54% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Equity | 20.14% | 26.07% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Assets (TTM) | 12.99% | 8.91% | GPT Healthcare Ltd. |
| Free Cash Flow (TTM) | $174.71M | $-83.80M | GPT Healthcare Ltd. |
| Dividend Yield | 2.44% | 0.11% | GPT Healthcare Ltd. |
| 1-Year Return | -1.29% | 12.35% | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Sales Ratio (TTM) | 2.49 | 5.39 | GPT Healthcare Ltd. |
| Enterprise Value | $11.77B | $26.69B | Dr. Agarwal's Eye Hospital Ltd. |
| EV/Revenue Ratio | 2.63 | 5.92 | GPT Healthcare Ltd. |
| Gross Profit Margin (TTM) | 62.58% | 78.09% | Dr. Agarwal's Eye Hospital Ltd. |
| Revenue per Share (TTM) | $55 | $952 | Dr. Agarwal's Eye Hospital Ltd. |
| Earnings per Share (Diluted) | $4.94 | $147.68 | Dr. Agarwal's Eye Hospital Ltd. |
| Beta (Stock Volatility) | 0.08 | -0.57 | Dr. Agarwal's Eye Hospital Ltd. |
GPT Healthcare Ltd. vs Dr. Agarwal's Eye Hospital Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| GPT Healthcare Ltd. | -0.63% | 0.03% | 4.02% | 19.68% | 4.37% | 5.03% |
| Dr. Agarwal's Eye Hospital Ltd. | 0.58% | 0.12% | -1.62% | 6.94% | -8.52% | -6.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| GPT Healthcare Ltd. | -1.29% | -22.71% | -22.71% | -22.71% | -22.71% | -22.71% |
| Dr. Agarwal's Eye Hospital Ltd. | 12.35% | 240.02% | 1,131.89% | 2,480.68% | 5,282.48% | 17,498.05% |
Performance & Financial Health Analysis: GPT Healthcare Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Market Information | ||
| Market Cap | ₹11.02B | ₹24.28B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 90,831 | 1,256 |
| 90 Day Avg. Volume | 169,613 | 1,378 |
| Last Close | ₹147.24 | ₹4,991.20 |
| 52 Week Range | ₹115.00 - ₹185.00 | ₹4,142.00 - ₹6,392.00 |
| % from 52W High | -20.41% | -21.91% |
| All-Time High | ₹219.90 (Feb 26, 2024) | ₹7,300.00 (Dec 30, 2024) |
| % from All-Time High | -33.04% | -31.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.22% |
| Quarterly Earnings Growth | -0.24% | 0.66% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.16% |
| Operating Margin (TTM) | 0.11% | 0.20% |
| Return on Equity (TTM) | 0.20% | 0.26% |
| Debt to Equity (MRQ) | 38.28 | 106.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹30.88 | ₹668.22 |
| Cash per Share (MRQ) | ₹4.08 | ₹191.98 |
| Operating Cash Flow (TTM) | ₹631.61M | ₹738.70M |
| Levered Free Cash Flow (TTM) | ₹499.22M | ₹546.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.44% | 0.11% |
| Last 12-Month Dividend | ₹3.50 | ₹5.00 |
Valuation & Enterprise Metrics Analysis: GPT Healthcare Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | GPTHEALTH (Apr 24, 2026) | DRAGARWQ (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 27.54 | 34.01 |
| Forward P/E | 17.67 | 516.77 |
| PEG Ratio | -1.17 | 1.81 |
| Price to Sales (TTM) | 2.49 | 5.39 |
| Price to Book (MRQ) | 4.41 | 7.52 |
| Market Capitalization | ||
| Market Capitalization | ₹11.02B | ₹24.28B |
| Enterprise Value | ₹11.77B | ₹26.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.63 | 5.92 |
| Enterprise to EBITDA | 17.00 | 20.64 |
| Risk & Other Metrics | ||
| Beta | 0.08 | -0.57 |
| Book Value per Share (MRQ) | ₹30.88 | ₹668.22 |
Financial Statements Comparison: GPT Healthcare Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | GPTHEALTH (2025) | DRAGARWQ (2025) |
|---|---|---|
| Revenue/Sales | 4.06B | 3.94B |
| Cost of Goods Sold | 1.47B | 896.20M |
| COGS % of Revenue | 36.2% | 22.8% |
| Gross Profit | 2.59B | 3.04B |
| Gross Margin | 63.8% | 77.2% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 671.21M | 813.30M |
| Operating Margin | 16.5% | 20.6% |
| EBITDA | 927.08M | 1.22B |
| EBITDA Margin | 22.8% | 31.1% |
| Pre-Tax Income | 693.46M | 707.00M |
| Pre-Tax Income % of Revenue | 17.1% | 17.9% |
| Income Tax | 194.24M | 160.50M |
| Income Tax % of Revenue | 4.8% | 4.1% |
| Net Income (Profit) | 499.22M | 546.50M |
| Profit Margin | 12.3% | 13.9% |
Balance Sheet & Liquidity Metrics
| Metric | GPTHEALTH (2025) | DRAGARWQ (2025) |
|---|---|---|
| Cash & Equivalents | 16.59M | 111.60M |
| Total Current Assets | 788.16M | 559.40M |
| Total Current Assets % of Revenue | 19.4% | 14.2% |
| Total Current Liabilities | 742.43M | 869.80M |
| Total Current Liabilities % of Revenue | 18.3% | 22.1% |
| Long-Term Debt | 227.25M | 3.06B |
| Long-Term Debt % of Revenue | 5.6% | 77.6% |
| Total Shareholders Equity | 2.48B | 2.10B |
| Retained Earnings | 887.46M | 1.99B |
| Retained Earnings % of Revenue | 21.8% | 50.4% |
| Property, Plant & Equipment | 2.27B | 1.37B |
Cash Flow Statement Comparison
| Metric | GPTHEALTH (2025) | DRAGARWQ (2025) |
|---|---|---|
| Operating Cash Flow | 631.61M | 738.70M |
| Operating Cash Flow % of Revenue | 15.5% | 18.8% |
| Capital Expenditures | -494.37M | 4.10M |
| Free Cash Flow | 174.71M | -83.80M |
| FCF Margin | 4.3% | -2.1% |
| Debt Repayment | -87.55M | -111.30M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 82.05M | 4.83M |
| Float Shares | 26.97M | 1.08M |
| % Held by Insiders | 65.57% | 77.59% |
| % Held by Institutions | 7.45% | 3.57% |
| % Held by Public | 26.98% | 18.84% |
Dividend Analysis & Yield Comparison: GPT Healthcare Ltd. vs Dr. Agarwal's Eye Hospital Ltd.
| Metric | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Last 12-Month Dividend | ₹3.50 | ₹5.00 |
| Last 12-Month Dividend Yield | 2.44% | 0.11% |
| 3-Year Avg Annual Dividend | ₹2.00 | ₹4.50 |
| 3-Year Avg Dividend Yield | 0.70% | 0.12% |
| 3-Year Total Dividends | ₹6.00 | ₹13.50 |
| Ex-Dividend Date | Nov 14, 2025 | Nov 08, 2024 |